Published in J Infect Dis on June 01, 2003
Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children. Pediatr Blood Cancer (2010) 2.37
Risk factors for seropositivity to Kaposi sarcoma-associated herpesvirus among children in Uganda. J Acquir Immune Defic Syndr (2013) 1.51
Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa. BMC Infect Dis (2008) 1.45
Kaposi sarcoma-associated herpesvirus (KSHV) seroprevalence in population-based samples of African children: evidence for at least 2 patterns of KSHV transmission. J Infect Dis (2009) 1.22
Substantial regional differences in human herpesvirus 8 seroprevalence in sub-Saharan Africa: insights on the origin of the "Kaposi's sarcoma belt". Int J Cancer (2010) 1.18
Human herpesvirus-8 infection and oral shedding in Amerindian and non-Amerindian populations in the Brazilian Amazon region. J Infect Dis (2007) 1.16
Early childhood infection by human herpesvirus 8 in Zambia and the role of human immunodeficiency virus type 1 coinfection in a highly endemic area. Am J Epidemiol (2008) 1.11
Human herpesvirus 8 infection in children and adults in a population-based study in rural Uganda. J Infect Dis (2011) 1.05
Classic Kaposi's sarcoma in Italy, 1985-1998. Br J Cancer (2005) 1.01
Sex and geographic patterns of human herpesvirus 8 infection in a nationally representative population‐based sample in Uganda. J Infect Dis (2010) 0.97
Seroprevalence and determinants of human herpes virus 8 infection in adult Nigerians with and without HIV-1 infection. Afr Health Sci (2011) 0.94
Saliva and the transmission of human herpesvirus 8: potential role of promoter-arthropod bites. J Infect Dis (2004) 0.93
Seroprevalence and risk factors for human herpesvirus 8 infection, rural Egypt. Emerg Infect Dis (2008) 0.92
Human herpesvirus 8 seropositivity among sexually active adults in Uganda. PLoS One (2011) 0.92
Anogenital Lesions: Kaposi's Sarcoma and Its Mimicks. ISRN AIDS (2012) 0.89
The viral etiology of AIDS-associated malignancies. Adv Pharmacol (2008) 0.89
Knowledge and practice of prechewing/prewarming food by HIV-infected women. Pediatrics (2011) 0.89
HIV and human herpesvirus 8 co-infection across the globe: Systematic review and meta-analysis. Int J Cancer (2015) 0.86
Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort study. J Acquir Immune Defic Syndr (2014) 0.85
Changes in the pattern of Kaposi's sarcoma at Ocean Road Cancer Institute in Tanzania (2006-2011). Int J STD AIDS (2014) 0.83
Cancer risk in persons with HIV/AIDS in India: a review and future directions for research. Infect Agent Cancer (2009) 0.83
Risk factors for early childhood infection of human herpesvirus-8 in Zambian children: the role of early childhood feeding practices. Cancer Epidemiol Biomarkers Prev (2013) 0.82
The Zambia Children's KS-HHV8 Study: rationale, study design, and study methods. Am J Epidemiol (2011) 0.82
Human herpesvirus-8 (HHV-8) sero-detection and HIV association in Kaposi's sarcoma (KS), non-KS tumors and non-neoplastic conditions. Infect Agent Cancer (2008) 0.82
A population-based study of how children are exposed to saliva in KwaZulu-Natal Province, South Africa: implications for the spread of saliva-borne pathogens to children. Trop Med Int Health (2010) 0.81
Diverse genotypes of Kaposi's sarcoma associated herpesvirus (KSHV) identified in infant blood infections in African childhood-KS and HIV/AIDS endemic region. J Med Virol (2007) 0.81
H. pylori-infection and antibody immune response in a rural Tanzanian population. Infect Agent Cancer (2006) 0.81
Early childhood infection of Kaposi's sarcoma-associated herpesvirus in Zambian households: a molecular analysis. Int J Cancer (2012) 0.80
Epidemiology and transmission of Kaposi's sarcoma-associated herpesvirus. Viruses (2014) 0.80
A population-based study of Kaposi Sarcoma-associated herpesvirus seropositivity in Uganda using principal components analysis. Infect Agent Cancer (2013) 0.78
Transmission of human herpesvirus type 8 infection within families in american indigenous populations from the Brazilian Amazon. J Infect Dis (2012) 0.78
A major locus on chromosome 3p22 conferring predisposition to human herpesvirus 8 infection. Eur J Hum Genet (2012) 0.78
High seroprevalence of antibodies against Kaposi's sarcoma-associated herpesvirus (KSHV) among HIV-1-infected children and adolescents in a non-endemic population. Med Microbiol Immunol (2016) 0.77
A Review of Human Herpesvirus 8, the Kaposi's Sarcoma-Associated Herpesvirus, in the Pediatric Population. J Pediatric Infect Dis Soc (2013) 0.77
Human herpesvirus 8 seropositivity in rural Uganda: maturation of sero-epidemiological studies. J Infect Dis (2011) 0.77
Mortality among HIV-1- and human herpesvirus type 8-affected mother-infant pairs in Zambia. Cancer Epidemiol Biomarkers Prev (2008) 0.75
Detection of Human Herpes Virus 8 in Kaposi's sarcoma tissues at the University Teaching Hospital, Lusaka, Zambia. Pan Afr Med J (2017) 0.75
Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol (2011) 12.10
Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ (2004) 11.96
Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS (2006) 7.08
Prediction error estimation: a comparison of resampling methods. Bioinformatics (2005) 6.41
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nat Genet (2013) 6.19
Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer (2008) 6.13
On criteria for evaluating models of absolute risk. Biostatistics (2005) 5.71
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood (2009) 5.69
Spectrum of cancer risk among US solid organ transplant recipients. JAMA (2011) 4.99
Merkel cell carcinoma and HIV infection. Lancet (2002) 4.72
Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst (2011) 4.69
Pathway analysis by adaptive combination of P-values. Genet Epidemiol (2009) 4.48
Age at cancer diagnosis among persons with AIDS in the United States. Ann Intern Med (2010) 4.30
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol (2006) 4.13
Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer (2003) 4.02
Cancer risk prediction models: a workshop on development, evaluation, and application. J Natl Cancer Inst (2005) 3.75
Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. Lancet Oncol (2008) 3.60
Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst (2009) 3.58
Methods for etiologic and early marker investigations in the PLCO trial. Mutat Res (2005) 3.33
The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2011) 3.29
Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst (2006) 3.17
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer. Cancer Prev Res (Phila) (2011) 3.03
Prevalence of monoclonal gammopathy of undetermined significance among men in Ghana. Mayo Clin Proc (2007) 2.91
MC1R germline variants confer risk for BRAF-mutant melanoma. Science (2006) 2.84
Age-related crossover in breast cancer incidence rates between black and white ethnic groups. J Natl Cancer Inst (2008) 2.64
MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J Natl Cancer Inst (2005) 2.57
Colorectal cancer risk prediction tool for white men and women without known susceptibility. J Clin Oncol (2008) 2.56
Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS). Blood (2011) 2.54
Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst (2002) 2.38
Spectrum of cancer risk late after AIDS onset in the United States. Arch Intern Med (2010) 2.33
Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007. JAMA (2011) 2.31
Elevated risk of lung cancer among people with AIDS. AIDS (2007) 2.20
Conservation of virally encoded microRNAs in Kaposi sarcoma--associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric Castleman disease. J Infect Dis (2007) 2.17
Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med (2011) 2.16
The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania. J Infect Dis (2007) 2.14
Identifying individuals at high risk of melanoma: a practical predictor of absolute risk. J Clin Oncol (2006) 2.05
Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database. Blood (2004) 2.05
No evidence of sexual transmission of Kaposi's sarcoma herpes virus in a heterosexual South African population. AIDS (2008) 1.99
Obesity is associated with an increased risk of monoclonal gammopathy of undetermined significance among black and white women. Blood (2010) 1.98
Prediagnosis body mass index, physical activity, and mortality in endometrial cancer patients. J Natl Cancer Inst (2013) 1.96
Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons. Cancer Epidemiol Biomarkers Prev (2008) 1.96
Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr (2003) 1.96
Risk factor modification and projections of absolute breast cancer risk. J Natl Cancer Inst (2011) 1.94
Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J Natl Cancer Inst (2006) 1.90
Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study. Blood (2010) 1.89
Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission. J Infect Dis (2007) 1.88
Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States. AIDS (2014) 1.86
Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study. Carcinogenesis (2006) 1.83
Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH. Gastroenterology (2006) 1.81
Hepatocellular carcinoma and other liver disease among Greenlanders chronically infected with hepatitis B virus: a population-based study. J Natl Cancer Inst (2011) 1.80
Probability of detecting disease-associated single nucleotide polymorphisms in case-control genome-wide association studies. Biostatistics (2007) 1.75
MC1R variants increase risk of melanomas harboring BRAF mutations. J Invest Dermatol (2008) 1.72
Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma. Cancer Lett (2011) 1.71
Divergent cancer pathways for early-onset and late-onset cutaneous malignant melanoma. Cancer (2009) 1.71
Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Defic Syndr (2005) 1.71
An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease. Clin Infect Dis (2010) 1.70
Provirus load in breast milk and risk of mother-to-child transmission of human T lymphotropic virus type I. J Infect Dis (2004) 1.69
Impact of the HIV epidemic on the incidence rates of anal cancer in the United States. J Natl Cancer Inst (2012) 1.67
Comparison of age distribution patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev (2006) 1.65
Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden. Blood (2013) 1.64
Mother-to-child transmission of human herpesvirus-8 in South Africa. J Infect Dis (2004) 1.64
Seroprevalence of human herpesvirus 8 among injection drug users in San Francisco. J Infect Dis (2003) 1.62
Evaluation of multiplexed cytokine and inflammation marker measurements: a methodologic study. Cancer Epidemiol Biomarkers Prev (2011) 1.60
Familial aggregation of Hodgkin lymphoma and related tumors. Cancer (2004) 1.60
Circulating inflammation markers and prospective risk for lung cancer. J Natl Cancer Inst (2013) 1.59
Use of surveillance, epidemiology, and end results-medicare data to conduct case-control studies of cancer among the US elderly. Am J Epidemiol (2011) 1.59
Validation of a colorectal cancer risk prediction model among white patients age 50 years and older. J Clin Oncol (2008) 1.59
Cumulative incidence of cancer after solid organ transplantation. Cancer (2013) 1.58
Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States. Cancer (2010) 1.54
Decreased urinary beta-defensin-1 expression as a biomarker of response to arsenic. Toxicol Sci (2008) 1.54
Host immunogenetics and control of human herpesvirus-8 infection. J Infect Dis (2006) 1.52
Long-term overall and disease-specific mortality associated with benign gynecologic surgery performed at different ages. Menopause (2014) 1.51
Risk factors for seropositivity to Kaposi sarcoma-associated herpesvirus among children in Uganda. J Acquir Immune Defic Syndr (2013) 1.51
Water, socioeconomic factors, and human herpesvirus 8 infection in Ugandan children and their mothers. J Acquir Immune Defic Syndr (2005) 1.51
Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma. Arthritis Rheum (2008) 1.50
Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma. AIDS (2003) 1.49
Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy era. J Acquir Immune Defic Syndr (2010) 1.47
Graphical methods for class prediction using dimension reduction techniques on DNA microarray data. Bioinformatics (2003) 1.47
Four-antigen mixture containing v-cyclin for serological screening of human herpesvirus 8 infection. Clin Vaccine Immunol (2009) 1.45
Merkel cell carcinoma: incidence, mortality, and risk of other cancers. J Natl Cancer Inst (2010) 1.43
Genetic susceptibility to severe infection in families with invasive pneumococcal disease. Am J Epidemiol (2008) 1.42
Cancer risk among patients with myotonic muscular dystrophy. JAMA (2011) 1.38
Evaluation of apolipoprotein A1 and posttranslationally modified forms of transthyretin as biomarkers for ovarian cancer detection in an independent study population. Cancer Epidemiol Biomarkers Prev (2006) 1.36
Incidence and geographic distribution of endemic Burkitt lymphoma in northern Uganda revisited. Int J Cancer (2008) 1.35
Predictors of herpes simplex virus type 2 prevalence and incidence among bar and hotel workers in Moshi, Tanzania. J Infect Dis (2007) 1.33
Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study. Int J Cancer (2004) 1.32
Simian immunodeficiency virus integration preference is similar to that of human immunodeficiency virus type 1. J Virol (2005) 1.30
Elevated risk for squamous cell carcinoma of the conjunctiva among adults with AIDS in the United States. Int J Cancer (2008) 1.27
Prevalence of Kaposi's sarcoma-associated herpesvirus infection in sex workers and women from the general population in Spain. Int J Cancer (2002) 1.27
Performance of high-throughput DNA quantification methods. BMC Biotechnol (2003) 1.27
Human herpesvirus 8 infection and transfusion history in children with sickle-cell disease in Uganda. J Natl Cancer Inst (2003) 1.26